PSMA7 and colon adenocarcinoma: The uterine carcinosarcoma (UCS) cases carried the utmost amplification incidence of PSMA7 (~ 8.8%), followed by colon adenocarcinoma (COAD) (~ 6.7%) and OV (~ 6.2%).